Is MBIN a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for Merchants Bancorp (MBIN) rests on Multi-family and healthcare finance niche: MBIN's core edge is its concentration in government-sponsored FHA multi-family, skilled-nursing, and healthcare-facility lending, a specialized market with high barriers and recurring servicing income. Revenue (Q1 2026) is ~$175M. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: MBIN's loan-to-deposit ratio has climbed to roughly 124 percent, forcing reliance on external wholesale funding that now approaches 30 percent of gross loans, which raises funding cost and liquidity risk. Whether MBIN is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Merchants Bancorp (NASDAQ: MBIN), headquartered in Carmel, Indiana and founded in 1990, is a bank holding company that runs three segments: Multi-family Mortgage Banking (originating and servicing government-sponsored FHA multi-family, healthcare, and bridge/construction loans), Mortgage Warehousing (funding agency-eligible residential loans and commercial lines for non-depository lenders), and Banking (retail, commercial, agricultural, SBA, and correspondent residential mortgage banking). This mix makes it less like a plain community bank and more like a specialized housing-finance and warehouse lender that has grown total assets to a record of roughly $20.3 billion. The investment picture is one of a rapidly scaling niche bank trading at a modest valuation. Q1 2026 net income rose about 16 percent year over year and the stock carries a price-to-earnings ratio around 11, well below broad-market averages, while tangible book value per share reached roughly $38.55. The bull case rests on continued balance-sheet growth and durable fee income from mortgage banking, and the bear case centers on a stretched loan-to-deposit ratio, reliance on external funding, and credit exposure tied to multi-family real estate and warehouse counterparties.
What's the case for buying MBIN?
1. Multi-family and healthcare finance niche
MBIN's core edge is its concentration in government-sponsored FHA multi-family, skilled-nursing, and healthcare-facility lending, a specialized market with high barriers and recurring servicing income. This segment drives both loan growth and noninterest income, which nearly doubled year over year in Q1 2026. Sustained demand for affordable and need-based housing finance supports the pipeline.
2. Balance-sheet growth and scale
Total assets reached a record of roughly $20.3 billion, with loans receivable near $11.4 billion and loans held for sale around $4.7 billion. Continued growth in loans and warehouse balances can lift net interest income if funding costs stay contained. Scale also spreads fixed costs across a larger earning-asset base.
3. Fee income and mortgage banking cyclicality
Noninterest income from mortgage warehousing, servicing, and gain-on-sale gives MBIN a revenue stream that can outpace spread income when volumes are strong. Q1 2026 noninterest income of roughly $46.6 million helped push revenue up about 20 percent year over year. This fee engine can offset periods of margin pressure but is itself sensitive to rate and refinancing cycles.
4. Cheap valuation and capital returns
The stock trades around 11 times earnings with a modest dividend yield near 0.9 percent, leaving room for re-rating if the market gains confidence in credit and funding. Growing tangible book value per share compounds intrinsic value over time. A low payout ratio preserves capital to fund loan growth.
What are the risks to MBIN?
MBIN's loan-to-deposit ratio has climbed to roughly 124 percent, forcing reliance on external wholesale funding that now approaches 30 percent of gross loans, which raises funding cost and liquidity risk. Net interest income has been roughly flat for two years, and net interest income fell about 7 percent year over year in Q1 2026 even as margin ticked up, signaling ongoing spread pressure. Credit exposure is concentrated in multi-family real estate, construction, and warehouse lending to non-depository counterparties, all sensitive to interest rates and commercial-property stress. Rising collateral-preservation and deposit-insurance expenses tied to problem assets have pressured noninterest expense. As a fast-growing lender, its results can be volatile and dependent on continued access to affordable funding.
How is MBIN valued? (as of JULY 2026)
Snapshot for MBIN as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Market cap: ~$2.1B
- Revenue (Q1 2026): ~$175M
- Net income (Q1 2026): ~$67.7M
- Diluted EPS (Q1 2026): ~$1.25
- P/E ratio: ~11.5x
- Total assets: ~$20.3B
Q1 2026 net income of roughly $67.7 million (about $1.25 per diluted share) rose around 16 percent year over year and came in ahead of consensus, with revenue up about 20 percent to roughly $175 million. The stock trades near 11 times earnings, a discount to broad-market averages that reflects funding and credit concerns. Tangible book value per share of about $38.55 and a low payout ratio leave capital available to fund continued loan growth.
How do you decide if MBIN is a buy?
Rather than asking whether MBIN is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold MBIN indirectly through an index or sector ETF before adding more.
For the full picture, see the MBIN stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about MBIN against your real portfolio and see your actual exposure before deciding.
The bottom line on MBIN
The bottom line: Merchants Bancorp's story right now is Multi-family and healthcare finance niche, with revenue (q1 2026) at ~$175M. If you believe that narrative continues, the call is about sizing MBIN sensibly and checking overlap with what you own; if you doubt it (the risk: mBIN's loan-to-deposit ratio has climbed to roughly 124 percent, forcing reliance on external wholesale funding that now approaches 30 percent of gross loans, which raises funding cost and liquidity risk.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around MBIN with Walnut
Use Merchants Bancorp as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is MBIN a good stock to buy right now?
+
The case for Merchants Bancorp right now is Multi-family and healthcare finance niche, with revenue (q1 2026) at ~$175M. If you believe that thesis holds, MBIN is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is mBIN's loan-to-deposit ratio has climbed to roughly 124 percent, forcing reliance on external wholesale funding that now approaches 30 percent of gross loans, which raises funding cost and liquidity risk. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Merchants Bancorp do?
+
Merchants Bancorp (NASDAQ: MBIN), headquartered in Carmel, Indiana and founded in 1990, is a bank holding company that runs three segments: Multi-family Mortgage Banking (originati
What are the main risks of MBIN?
+
MBIN's loan-to-deposit ratio has climbed to roughly 124 percent, forcing reliance on external wholesale funding that now approaches 30 percent of gross loans, which raises funding cost and liquidity risk. Net interest income has been roughly flat for two years, and net interest income fell about 7 percent year over year in Q1 2026 even as margin ticked up, signaling ongoing spread pressure. Credit exposure is concentrated in multi-family real estate, construction, and warehouse lending to non-depository counterparties, all sensitive to interest rates and commercial-property stress. Rising collateral-preservation and deposit-insurance expenses tied to problem assets have pressured noninterest expense. As a fast-growing lender, its results can be volatile and dependent on continued access to affordable funding.
What does Merchants Bancorp do?
+
Merchants Bancorp is an Indiana-based bank holding company that operates in three segments: multi-family mortgage banking (FHA and healthcare-facility lending), mortgage warehousing (funding non-depository lenders), and traditional banking (retail, commercial, agricultural, and SBA lending).
Is MBIN a regional bank or something more specialized?
+
It is legally a bank holding company but functions more like a specialized housing-finance and warehouse lender. Its largest earnings drivers are government-sponsored multi-family and healthcare lending plus mortgage warehousing, which sets it apart from a typical deposit-funded community bank.
How did MBIN perform in its most recent quarter?
+
In Q1 2026, Merchants Bancorp reported net income of roughly $67.7 million (about $1.25 per diluted share), up around 16 percent year over year, on revenue of roughly $175 million, with total assets reaching a record of about $20.3 billion.
Why does MBIN trade at such a low P/E?
+
The stock trades near 11 times earnings, below broad-market averages, largely because investors discount its high loan-to-deposit ratio, reliance on wholesale funding, and credit exposure to multi-family real estate and warehouse counterparties. The low multiple reflects those risks alongside its growth.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell MBIN; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.